PRODUCT

Introduction to Boryung
caring for people’s health

Main Products

A guide to Boryung’ main
products.

Products

A guide to all
Boryung’s products.

close

R&D

The Boryung Company,
envisioning a world with a
healthy mankind.

R&D Vision·Strategy

Boryung’ goal is to develop
into a global company.

Pipeline

The research team at Boryung
aims to lead the future of the
pharmaceutical industry.

close

GLOBAL
BUSINESS

An introduction of
Boryung’ global business.

Introduction

The best global company.

CMO

Introducing BRCMO business

Network

50 markets and 150 partners worldwide.

close

PR

An introduction of Boryung ’ value -
Envisioning a healthy mankind.

Advertising

An introduction of video
and printed advertisements of Boryung.

close

Directions

An introduction of Boryung
Pharmaceutical’ value - Envisioning
a healthy mankind.

Directions

An introduction of video
and printed advertisements of Boryung.

close

Financial Information

Summary of Consolidated Statements of Financial Position

(Unit : KRW 1,000,000 / As of December 31, 2022)

Summary of Consolidated Statements of Financial Position
Financial items 2022 2021 2020
Current assets 338,378 437,314 315,660
Non-current assets 554,008 391,327 332,334
Total assets 892,386 828,641 647,994
Current liabilities 227,483 155,953 122,871
Non-current liabilities 98,489 198,374 184,835
Total liabilities 375,969 354,327 307,706
Share capital 34,345 34,345 23,810
Other paid-in capital and Other components of equity 105,393 104,691 20,284
Retained earnings 376,179 334,827 295,816
Total equity 516,417 474,314 340,288

Summary of Consolidated Statements of Comprehensive Income

(Unit : KRW 1,000,000 / As of December 31, 2022)

Summary of Consolidated Statements of Comprehensive Income
Financial items 2022 2021 2020
Revenue 760,476 627,279 561,867
Cost of sales 453,289 362,342 330,425
Gross profit 307,187 264,937 231,442
Selling and administrative expenses 208,879 184,343 155,949
R&D expenses 41,705 39,146 35,506
Operating profit 56,603 41,448 39,986
Finance income 37,461 11,916 658
Finance costs 21,375 5,156 4,204
Other income 2,317 1,377 1,938
Other expenses 11,980 4,320 2,334
Share of loss of associates -4,154 25,453 0
Profit before income tax 58,872 70,718 36,044
Income tax expense 16,934 27,599 9,184
Profit for the year 41,938 43,119
26,860
Total comprehensive income for the year 48,796 44,409 25,494

Major financial ratio

(As of December 31, 2022)

Major financial ratio
Financial items 2022 2021 2020
Revenue growth rate 21.23% 11.64% 7.17%
Profit growth rate -2.74% 60.53% -16.64%
ROA 4.87% 5.84% 4.65%
ROE 8.47% 10.59% 8.62%
Debt ratio 72.80% 74.70% 90.43%
Reserve ratio 1095.30% 974.89% 1242.40%
Interest coverage ratio (times) 9.24 9.26 11.96

Analysis on profitability

(As of December 31, 2022)

Analysis on profitability
Financial items 2022 2021 2020
Gross profit margin 40.39% 42.24% 41.19%
R&D investment ratio 6.09% 6.64% 6.32%
Selling and administrative expenses ratio 27.47% 29.39% 27.76%
Operating profit margin 7.44% 6.61% 7.12%
Profit ratio for the year 5.51% 6.87% 4.78%
TOP